Nanostructured lipid carriers (NLCs): A comprehensive review of drug delivery advancements
DOI:
https://doi.org/10.69857/joapr.v13i2.676Keywords:
Nano-structured lipid carriers, Targeted Drug Delivery, Controlled release, BioavailabilityAbstract
Background: Nano-structured lipid carriers (NLCs) have emerged as a significant advancement in lipid-based drug delivery systems. Compared to Solid Lipid Nanoparticles (SLNs), NLCs offer improved drug loading capacity, stability, and controlled release profiles. Objective: This review article explores the structural and functional benefits of NLCs, their enhanced bioavailability, and their potential in targeted therapeutic agent delivery. Methodology: We investigated the unique combination of solid and liquid lipids in NLCs, which creates an internal structure for improved drug encapsulation and sustained release. Various methods were analyzed for their contribution to NLC efficacy, including high-pressure homogenization and solvent emulsification. Results and Discussion: NLCs demonstrated encapsulation efficiency ranging from 85–95%, with particle sizes between 100–300 nm. Drug release was sustained over 24 hours, affirming their effectiveness in controlled drug delivery. Applications of NLCs were highlighted across diverse delivery modes, including topical, pulmonary, oral, parenteral, and ocular. Challenges such as scaling production, overcoming biological barriers, and ensuring regulatory compliance were also addressed. Conclusion: NLCs present a promising future in pharmaceutical sciences, with the potential to improve therapeutic outcomes in complex diseases like cancer and neurodegenerative disorders. Continued research into NLC formulations is critical for advancing patient outcomes and addressing global health challenges.
Downloads
References
Apostolou M, Fatokun AA, Assi S, Khan I. Targeted Lipid-Based Drug Delivery Systems for Lung Cancer Therapy. Applied Sciences 14, 6759 (2024) https://doi.org/10.3390/APP14156759.
Leal Filho W, Frankenberger F, Salvia AL, Azeiteiro U, Alves F, Castro P, Will M, Platje J, Lovren VO, Brandli L, Price E, Doni F, Mifsud M, Ávila LV. A framework for the implementation of the Sustainable Development Goals in university programmes. J Clean Prod, 299, 126915 (2021) https://doi.org/10.1016/J.JCLEPRO.2021.126915.
Nguyen VH, Thuy VN, Van TV, Dao AH, Lee BJ. Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration. OpenNano, 8, 100064 (2022) https://doi.org/10.1016/J.ONANO.2022.100064.
Ashfaq R, Rasul A, Asghar S, Kovács A, Berkó S, Budai-Szűcs M. Lipid Nanoparticles: An Effective Tool to Improve the Bioavailability of Nutraceuticals. International Journal of Molecular Sciences, 24, 15764 (2023) https://doi.org/10.3390/IJMS242115764.
Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Liposomes: Advancements and innovation in the manufacturing process. Adv Drug Deliv Rev, 154–155, 102–22 (2020) https://doi.org/10.1016/J.ADDR.2020.07.002.
Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 47, 165-196 (2001) https://doi.org/10.1016/S0169-409X(01)00105-3.
Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Curr Med Chem, 27, 3623-3656 (2020) https://doi.org/10.2174/0929867326666190624155938.
Viegas C, Patrício AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics 15, 1593 (2023) https://doi.org/10.3390/PHARMACEUTICS15061593.
Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm, 242, 121-8 (2002) https://doi.org/10.1016/S0378-5173(02)00180-1.
Weber S, Zimmer A, Pardeike J. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 86, 7–22 (2014) https://doi.org/10.1016/J.EJPB.2013.08.013.
Izza N, Suga K, Okamoto Y, Watanabe N, Bui TT, Wibisono Y, Fadila CR, Umakoshi H. Systematic Characterization of Nanostructured Lipid Carriers from Cetyl Palmitate/Caprylic Triglyceride/Tween 80 Mixtures in an Aqueous Environment. Langmuir, 37, 4284-4293 (2021) https://doi.org/10.1021/acs.langmuir.1c00270.
Viegas C, Patrício AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics 15, 1593 (2023) https://doi.org/10.3390/PHARMACEUTICS15061593.
Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. Journal of Controlled Release, 171, 345-57 (2013) https://doi.org/10.1016/j.jconrel.2013.04.018.
Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces, 162, 236-245 (2018) https://doi.org/10.1016/j.colsurfb.2017.11.064.
Nguyen VH, Thuy VN, Van TV, Dao AH, Lee BJ. Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration. OpenNano, 8, 100064 (2022) https://doi.org/10.1016/J.ONANO.2022.100064.
Soni K, Rizwanullah M, Kohli K. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Artif Cells Nanomed Biotechnol, 46, 15-31 (2018) https://doi.org/10.1080/21691401.2017.1408124.
Nagar L, Gulati N, Saini A, Singh S, Gupta G, MacLoughlin R, Chellappan DK, Dua K, Dureja H. Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD). Curr Drug Deliv, 21, 1–13 (2024) https://doi.org/10.2174/0115672018289883240226113353.
Kasongo KW, Jansch M, Müller RH, Walker RB. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain. J Liposome Res, 21, 245-254 (2011) https://doi.org/10.3109/08982104.2010.539186.
Haider M, Abdin SM, Kamal L, Orive G. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics, 12, 288 (2020) https://doi.org/10.3390/PHARMACEUTICS12030288.
Karantonis C, Moreno-Rojas JM, Tang C-H, Chen H-L, Dong J-R. Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Food-Grade Nanovehicles for Hydrophobic Nutraceuticals or Bioactives. Applied Sciences, 13, 1726 (2023), https://doi.org/10.3390/APP13031726.
Viegas C, Seck F, Fonte P. An insight on lipid nanoparticles for therapeutic proteins delivery. J Drug Deliv Sci Technol, 77, 103839 (2022) https://doi.org/10.1016/J.JDDST.2022.103839.
Andonova V, Peneva P. Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC). Curr Pharm Des, 23, 6630-6642 (2018) https://doi.org/10.2174/1381612823666171115105721.
faheim samar, gardouh ahmed, nouh ahmed, ghorab mamdouh. Review article on nanoemulsions and nanostructured lipid carriers. Records of Pharmaceutical and Biomedical Sciences, 2, 23-31 (2018) https://doi.org/10.21608/rpbs.2018.5223.1011.
Mohite P, Singh S, Pawar A, Sangale A, Prajapati BG, John S. Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs. Frontiers in Drug Delivery, 3, 1232012 (2023) https://doi.org/10.3389/FDDEV.2023.1232012.
Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN®). J Microencapsul, 18, 149-158 (2001) https://doi.org/10.1080/02652040010000361.
Khan S, Sharma A, Jain V. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Adv Pharm Bull, 13, 446-60 (2023) https://doi.org/10.34172/apb.2023.056.
Graván P, Aguilera-Garrido A, Marchal JA, Navarro-Marchal SA, Galisteo-González F. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Adv Colloid Interface Sci, 314, 102871 (2023) https://doi.org/10.1016/J.CIS.2023.102871.
Xie B, Liu Y, Li X, Yang P, He W. Solubilization techniques used for poorly water-soluble drugs. Acta Pharm Sin B, 14, 4683-716 (2024) https://doi.org/10.1016/J.APSB.2024.08.027.
Pingale P, Kendre P, Pardeshi K, Rajput A. An emerging era in manufacturing of drug delivery systems: Nanofabrication techniques. Heliyon, 9, e14247 (2023) https://doi.org/10.1016/J.HELIYON.2023.E14247.
Bezelya A, Küçüktürkmen B, Bozkır A. Microfluidic Devices for Precision Nanoparticle Production. Micro, 3, 822-66 (2023) https://doi.org/10.3390/MICRO3040058.
Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm, 394, 179-185 (2010) https://doi.org/10.1016/j.ijpharm.2010.05.005.
Vitorino C, Almeida A, Sousa J, Lamarche I, Gobin P, Marchand S, Couet W, Olivier JC, Pais A. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: In vitro vs. in vivo studies. European Journal of Pharmaceutics and Biopharmaceutics, 86, 133-144 (2014) https://doi.org/10.1016/j.ejpb.2013.12.004.
Garud A, Singh D, Garud N. Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications. International Current Pharmaceutical Journal, 1, 384-393 (2012) https://doi.org/10.3329/icpj.v1i11.12065.
Souto EB, Müller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul, 23, 377-388 (2006) https://doi.org/10.1080/02652040500435295.
Arias JL, Barretta R, Nguyen T-T-L, Duong V-A. Solid Lipid Nanoparticles. Encyclopedia, 2, 952-73 (2022) https://doi.org/10.3390/ENCYCLOPEDIA2020063.
Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development. ACS Materials Au, 3, 600-19 (2023) https://doi.org/10.1021/ACSMATERIALSAU.3C00032/ASSET/IMAGES/LARGE/MG3C00032_0004.JPEG.
John R, Monpara J, Swaminathan S, Kalhapure R. Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up. Pharmaceutics, 16, 131 (2024) https://doi.org/10.3390/PHARMACEUTICS16010131.
Stefanov S, Gugleva V, Andonova V. Technological strategies for the preparation of lipid nanoparticles: an updated review. Pharmacia, 70, 449-63 (2023) https://doi.org/10.3897/PHARMACIA.70.E108119.
Chauhan AS, Chand P, Parashar T. Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy. BIO Integration, 6, 994 (2025) https://doi.org/10.15212/BIOI-2024-0107.
Albatrni H, Qiblawey H, El-Naas MH. Comparative study between adsorption and membrane technologies for the removal of mercury. Sep Purif Technol, 257, 117833 (2021) https://doi.org/10.1016/j.seppur.2020.117833.
Fang C-L, A. Al-Suwayeh S, Fang J-Y. Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting. Recent Pat Nanotechnol, 7, 41-45 (2012) https://doi.org/10.2174/18722105130105.
Mendes IT, Ruela ALM, Carvalho FC, Freitas JTJ, Bonfilio R, Pereira GR. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf B Biointerfaces, 177, 274-281 (2019) https://doi.org/10.1016/j.colsurfb.2019.02.007.
Doktorovová S, Araújo J, Garcia ML, Rakovský E, Souto EB. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B Biointerfaces, 75, 538-542 (2010) https://doi.org/10.1016/j.colsurfb.2009.09.033.
Garg J, Pathania K, Sah SP, Pawar S V. Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Futur J Pharm Sci, 8, 25 (2022) https://doi.org/10.1186/s43094-022-00414-8.
Hua X, Xu S, Wang M, Chen Y, Yang H, Yang R. Effects of high-speed homogenization and high-pressure homogenization on structure of tomato residue fibers. Food Chem, 232, 443-449 (2017) https://doi.org/10.1016/j.foodchem.2017.04.003.
Akanda M, Mithu MSH, Douroumis D. Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment. J Drug Deliv Sci Technol, 86, 104709 (2023) https://doi.org/10.1016/J.JDDST.2023.104709.
Juttulapa M, Piriyaprasarth S, Takeuchi H, Sriamornsak P. Effect of high-pressure homogenization on stability of emulsions containing zein and pectin. Asian J Pharm Sci, 12, 21-7 (2017) https://doi.org/10.1016/J.AJPS.2016.09.004.
Ren G, Sun Z, Wang Z, Zheng X, Xu Z, Sun D. Nanoemulsion formation by the phase inversion temperature method using polyoxypropylene surfactants. J Colloid Interface Sci, 540, 177-184 (2019) https://doi.org/10.1016/j.jcis.2019.01.018.
Zanini M, Cingolani A, Hsu CP, Fernández-Rodríguez MÁ, Soligno G, Beltzung A, Caimi S, Mitrano D, Storti G, Isa L. Mechanical phase inversion of Pickering emulsions via metastable wetting of rough colloids. Soft Matter, 15, 7888-900 (2019) https://doi.org/10.1039/C9SM01352K.
Dehghanghadikolaei A, Shahbaznezhad M, Abdul Halim B, Sojoudi H. Contactless Method of Emulsion Formation Using Corona Discharge. ACS Omega, 7, 7045-56 (2022) https://doi.org/10.1021/ACSOMEGA.1C06765/SUPPL_FILE/AO1C06765_SI_002.MP4.
Gao S, McClements DJ. Formation and stability of solid lipid nanoparticles fabricated using phase inversion temperature method. Colloids Surf A Physicochem Eng Asp, 499, 79-87 (2016) https://doi.org/10.1016/j.colsurfa.2016.03.065.
Corrias F, Lai F. New Methods for Lipid Nanoparticles Preparation. Recent Pat Drug Deliv Formul, 5, 201-213 (2011) https://doi.org/10.2174/187221111797200597.
Friberg SE, Corkery RW, Blute IA. Phase inversion temperature (PIT) emulsification process. J Chem Eng Data, 56, 4282-4290 (2011) https://doi.org/10.1021/je101179s.
Klettenhammer S, Ferrentino G, Morozova K, Scampicchio M. Novel Technologies Based on Supercritical Fluids for the Encapsulation of Food Grade Bioactive Compounds. Foods, 9, 1395 (2020) https://doi.org/10.3390/FOODS9101395.
Kamjam M, Ngamprasertsith S, Sawangkeaw R, Charoenchaitrakool M, Privat R, Jaubert JN, Molière M. The Great Versatility of Supercritical Fluids in Industrial Processes: A Focus on Chemical, Agri-Food and Energy Applications. Processes, 12, 2402 (2024) https://doi.org/10.3390/PR12112402.
Trucillo P, Campardelli R. Production of solid lipid nanoparticles with a supercritical fluid assisted process. Journal of Supercritical Fluids, 143, 16-23 (2019) https://doi.org/10.1016/j.supflu.2018.08.001.
Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles - Evaluation of the method and process parameters. European Journal of Pharmaceutics and Biopharmaceutics, 55, 125-131 (2003) https://doi.org/10.1016/S0939-6411(02)00130-3.
Mahor AK, Singh PP, Gupta R, Bhardwaj P, Rathore P, Kishore A, Goyal R, Sharma N, Verma J, Rosenholm JM, Bansal KK. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. J Nanotechnol, 2023, 4687959 (2023) https://doi.org/10.1155/2023/4687959.
Bhatt S, Sharma J, Singh M, Saini V. Solid Lipid Nanoparticles: A Promising Technology for Delivery of Poorly Water-Soluble Drugs. ACTA Pharmaceutica Sciencia, 56, 27-49 (2018) https://doi.org/10.23893/1307-2080.APS.05616.
García-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B Biointerfaces, 27, 159-168 (2003) https://doi.org/10.1016/S0927-7765(02)00053-X.
Li Z, Yu L, Zheng L, Geng F. Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method. J Therm Anal Calorim, 99, 686-693 (2010) https://doi.org/10.1007/s10973-009-0127-z.
Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine. Chem Pharm Bull (Tokyo), 58, 650-655 (2010) https://doi.org/10.1248/cpb.58.650.
Fonte P, Nogueira T, Gehm C, Ferreira D, Sarmento B. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv Transl Res, 1, 299-308 (2011) https://doi.org/10.1007/s13346-011-0023-5.
Trotta M, Carlotti ME, Gallarate M, Zara GP, Muntoni E, Battaglia L. Insulin-loaded SLN prepared with the emulsion dilution technique: In vivo tracking of nanoparticles after oral administration to rats. J Dispers Sci Technol, 32, 1041-1045 (2011) https://doi.org/10.1080/01932691.2010.488497.
Gallarate M, Trotta M, Battaglia L, Chirio D. Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation. J Microencapsul, 26, 394-402 (2009) https://doi.org/10.1080/02652040802390156.
Mendes IT, Ruela ALM, Carvalho FC, Freitas JTJ, Bonfilio R, Pereira GR. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf B Biointerfaces, 177, 274-281 (2019) https://doi.org/10.1016/j.colsurfb.2019.02.007.
Cirri M, Bragagni M, Mennini N, Mura P. Development of a new delivery system consisting in “drug - In cyclodextrin - In nanostructured lipid carriers” for ketoprofen topical delivery. European Journal of Pharmaceutics and Biopharmaceutics, 80, 46-53 (2012) https://doi.org/10.1016/j.ejpb.2011.07.015.
Sütő B, Berkó S, Kozma G, Kukovecz Á, Budai-Szucs M, Erös G, Kemény L, Sztojkov-Ivanov A, Gáspár R, Csányi E. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: Characterization and investigation of in vitro and in vivo penetration through the skin. Int J Nanomedicine, 11, 1201-1212 (2016) https://doi.org/10.2147/IJN.S99198.
Khalil RM, Abd-Elbary A, Kassem MA, Ghorab MM, Basha M. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam. Pharm Dev Technol, 19, 304-314 (2014) https://doi.org/10.3109/10837450.2013.778872.
Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Müller RH. Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation. Int J Pharm, 377, 207-214 (2009) https://doi.org/10.1016/j.ijpharm.2009.05.020.
Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 - Development, physicochemical characterization and in vitro release studies. European Journal of Pharmaceutics and Biopharmaceutics, 67, 141-148 (2007) https://doi.org/10.1016/j.ejpb.2007.01.015.
Patil-Gadhe A, Kyadarkunte A, Patole M, Pokharkar V. Montelukast-loaded nanostructured lipid carriers: Part II Pulmonary drug delivery and in vitro-in vivo aerosol performance. European Journal of Pharmaceutics and Biopharmaceutics, 88, 169-177 (2014) https://doi.org/10.1016/j.ejpb.2014.07.007.
Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A. Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm, 419, 329-338 (2011) https://doi.org/10.1016/j.ijpharm.2011.07.040.
Nafee N, Makled S, Boraie N. Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization. European Journal of Pharmaceutical Sciences, 125, 151-162 (2018) https://doi.org/10.1016/j.ejps.2018.10.003.
Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. Journal of Controlled Release, 113, 111-116 (2006) https://doi.org/10.1016/j.jconrel.2006.04.005.
Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: Apomorphine as a model drug. Nanotechnology, 21, 111-116 (2010) https://doi.org/10.1088/0957-4484/21/40/405101.
Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. European Journal of Pharmaceutical Sciences, 38, 138-146 (2009) https://doi.org/10.1016/j.ejps.2009.06.008.
Mu X, He GR, Yuan X, Li XX, Du GH. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav, 98, 286-291 (2011) https://doi.org/10.1016/j.pbb.2011.01.011.
Tsai MJ, Wu PC, Huang Y Bin, Chang JS, Lin CL, Tsai YH, Fang JY. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm, 423, 461-470 (2012) https://doi.org/10.1016/j.ijpharm.2011.12.009.
Esposito E, Mariani P, Ravani L, Contado C, Volta M, Bido S, Drechsler M, Mazzoni S, Menegatti E, Morari M, Cortesi R. Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study. European Journal of Pharmaceutics and Biopharmaceutics, 80, 306-314 (2012) https://doi.org/10.1016/j.ejpb.2011.10.015.
Liu R, Liu Z, Zhang C, Zhang B. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: Improving in vivo ocular bioavailability. J Pharm Sci, 101, 3833-3844 (2012) https://doi.org/10.1002/jps.23251.
Gade S, Patel KK, Gupta C, Anjum MM, Deepika D, Agrawal AK, Singh S. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea. J Pharm Sci, 108, 1-12 (2019) https://doi.org/10.1016/j.xphs.2019.04.005.
Araújo J, Nikolic S, Egea MA, Souto EB, Garcia ML. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf B Biointerfaces, 88, 150-157 (2011) https://doi.org/10.1016/j.colsurfb.2011.06.025.
Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology, 22, 045101 (2011) https://doi.org/10.1088/0957-4484/22/4/045101.
Gonzalez-Mira E, Nikolić S, Calpena AC, Egea MA, Souto EB, García ML. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels. J Pharm Sci, 101, 707-725 (2012) https://doi.org/10.1002/jps.22784.
Wathoni N, Suhandi C, Elamin KM, Lesmana R, Hasan N, Mohammed AFA, El-Rayyes A, Wilar G. Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications. Int J Nanomedicine, 19, 8091-113 (2024) https://doi.org/10.2147/IJN.S478964.
Kulkarni M, Patel K, Patel A, Patel S, Desai J, Patel M, Shah U, Patel A, Solanki N. Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review. ADMET DMPK, 12, 63-105 (2024) https://doi.org/10.5599/ADMET.2043.
Zhang W, Jiang Y, He Y, Boucetta H, Wu J, Chen Z, He W. Lipid carriers for mRNA delivery. Acta Pharm Sin B, 13, 4105-26 (2023) https://doi.org/10.1016/J.APSB.2022.11.026.
Balaraman AK, Moglad E, Afzal M, Babu MA, Goyal K, Roopashree R, Kaur I, Kumar S, Kumar Mr, Chauhan AS, Hemalatha S, Gupta G, Ali H. Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics. Clinica Chimica Acta, 567, 120105 (2025) https://doi.org/10.1016/J.CCA.2024.120105.
Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu H, Bonam SR, Kurapati R. Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines. Vaccines, 11, 658 (2023) https://doi.org/10.3390/VACCINES11030658.
Jasim SA, Ahmed AT, Kubaev A, Kyada A, Alshahrani MY, Sharma S, Al-Hetty HRAK, Vashishth R, Chauhan AS, Abosaoda MK. Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors. Medical Oncology, 41, 1-17 (2024) https://doi.org/10.1007/S12032-024-02529-9.
Liu D, Long M, Gao L, Chen Y, Li F, Shi Y, Gu N. Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management. Adv Funct Mater, 32, 2112258 (2022) https://doi.org/10.1002/ADFM.202112258.
Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal, 29, 999-1012 (2021) https://doi.org/10.1016/J.JSPS.2021.07.015.
De Carvalho M, Queiroz V, Muehlmann LA. Characteristics and Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers. Journal of Nanotheranostics, 5, 188-211 (2024) https://doi.org/10.3390/JNT5040012.
Patil-Gadhe A, Pokharkar V. Pulmonary targeting potential of rosuvastatin loaded nanostructured lipid carrier: Optimization by factorial design. Int J Pharm, 501, 199-210 (2016) https://doi.org/10.1016/j.ijpharm.2016.01.080.
Makled S, Boraie N, Nafee N. Nanoparticle-mediated macrophage targeting—a new inhalation therapy tackling tuberculosis. Drug Deliv Transl Res, 11, 1037–55 (2021) https://doi.org/10.1007/S13346-020-00815-3/METRICS.
Buya AB, Witika BA, Bapolisi AM, Mwila C, Mukubwa GK, Memvanga PB, Makoni PA, Nkanga CI. Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review. Pharmaceutics, 13, 2041 (2021) https://doi.org/10.3390/PHARMACEUTICS13122041.
Zhang S, Zhao X, Xue Y, Wang X, Chen XL. Advances in nanomaterial-targeted treatment of acute lung injury after burns. J Nanobiotechnology, 22, 1-21 (2024) https://doi.org/10.1186/S12951-024-02615-0/FIGURES/3.
Li SJ, Wang XJ, Hu JB, Kang XQ, Chen L, Xu XL, Ying XY, Jiang SP, Du YZ. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy. Drug Deliv, 24, 402-413 (2017) https://doi.org/10.1080/10717544.2016.1259369.
Kardara M, Hatziantoniou S, Sfika A, Vassiliou AG, Mourelatou E, Magkou C, Armaganidis A, Roussos C, Orfanos SE, Kotanidou A, Maniatis NA. Caveolar uptake and endothelial-protective effects of nanostructured lipid carriers in acid aspiration murine acute lung injury. Pharm Res, 30, 1836-1847 (2013) https://doi.org/10.1007/s11095-013-1027-2.
Ahmad N, Ahmad R, Alam MA, Ahmad FJ, Amir M, Pottoo FH, Sarafroz M, Jafar M, Umar K. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol, 128, 825-838 (2019) https://doi.org/10.1016/j.ijbiomac.2019.01.142.
Preetam S, Nahak BK, Patra S, Toncu DC, Park S, Syväjärvi M, Orive G, Tiwari A. Emergence of microfluidics for next generation biomedical devices. Biosens Bioelectron X, 10, 100106 (2022) https://doi.org/10.1016/j.biosx.2022.100106.
Sood S, Jain K, Gowthamarajan K. P1–382: Curcumin‐donepezil–loaded nanostructured lipid carriers for intranasal delivery in an Alzheimer’s disease model. Alzheimer’s & Dementia, 9, 299 (2013) https://doi.org/10.1016/j.jalz.2013.05.609.
Frozza RL, Salbego C, Bernardi A, Hoppe JB, Meneghetti A, Battastini AM, Guterres S, Pohlmann A. P1‐006: Incorporation of resveratrol into lipid‐core nanocapsules improves its cerebral bioavailability and reduces the Aβ‐induced toxicity. Alzheimer’s & Dementia, 7, S114-S114 (2011) https://doi.org/10.1016/j.jalz.2011.05.286.
Shehata MK, Ismail AA, Kamel MA. Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation. Int J Nanomedicine, 18, 1631-1658 (2023) https://doi.org/10.2147/IJN.S402447.
Chang KH, Chen CM. The Role of Oxidative Stress in Parkinson’s Disease. Antioxidants, 9, 597 (2020) https://doi.org/10.3390/ANTIOX9070597.
Hassan DM, El-Kamel AH, Allam EA, Bakr BA, Ashour AA. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson’s disease: interplay between nuclear factor-kappa β and cathepsin B. Drug Deliv Transl Res, 14, 400–17 (2024) https://doi.org/10.1007/S13346-023-01407-7/FIGURES/8.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshé SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia, 55, 475-482 (2014) https://doi.org/10.1111/epi.12550.
Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: In vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv, 12, 181-194 (2015) https://doi.org/10.1517/17425247.2014.945416.
Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomedicine, 6, 363-371 (2011) https://doi.org/10.2147/ijn.s15881.
Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R. Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries. Life Sci, 193, 64-76 (2018) https://doi.org/10.1016/j.lfs.2017.11.046.
Wavikar P, Pai R, Vavia P. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics. J Pharm Sci, 106, 3613-3622 (2017) https://doi.org/10.1016/j.xphs.2017.08.024.
Khan I, Hussein S, Houacine C, Khan Sadozai S, Islam Y, Bnyan R, Elhissi A, Yousaf S. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers. Int J Pharm, 598, 120376 (2021) https://doi.org/10.1016/J.IJPHARM.2021.120376.
Ahalwat S, Bhatt DC, Rohilla S, Jogpal V, Sharma K, Virmani T, Kumar G, Alhalmi A, Alqahtani AS, Noman OM, Almoiliqy M. Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals, 16, 1108 (2023) https://doi.org/10.3390/ph16081108.
Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm, 394, 179-185 (2010) https://doi.org/10.1016/j.ijpharm.2010.05.005.
Abo El-Enin HA, Elkomy MH, Naguib IA, Ahmed MF, Alsaidan OA, Alsalahat I, Ghoneim MM, Eid HM. Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route. Pharmaceuticals, 15, 281 (2022) https://doi.org/10.3390/ph15030281.
Neha SL, Mishra AK, Rani L, Paroha S, Dewangan HK, Sahoo PK. Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson’s disease. J Microencapsul, 40, 599-612 (2023) https://doi.org/10.1080/02652048.2023.2264386.
Hassan DM, El-Kamel AH, Allam EA, Bakr BA, Ashour AA. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson’s disease: interplay between nuclear factor-kappa β and cathepsin B. Drug Deliv Transl Res, 14, 400-417 (2024) https://doi.org/10.1007/s13346-023-01407-7.
Gabal YM, Kamel AO, Sammour OA, Elshafeey AH. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm, 473, 442-457 (2014) https://doi.org/10.1016/j.ijpharm.2014.07.025.
Gadhave DG, Kokare CR. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm, 45, 1520-5762 (2019) https://doi.org/10.1080/03639045.2019.1576724.
Ahmad MZ, Sabri AH Bin, Anjani QK, Domínguez-Robles J, Abdul Latip N, Hamid KA. Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery. Pharmaceuticals, 15, 370 (2022) https://doi.org/10.3390/ph15030370.
Nair SC, Vinayan KP, Mangalathillam S. Nose to brain delivery of phenytoin sodium loaded nano lipid carriers: Formulation, drug release, permeation and in vivo pharmacokinetic studies. Pharmaceutics, 13, 1640 (2021) https://doi.org/10.3390/pharmaceutics13101640.
Motawea A, Borg T, Abd El-Gawad AEGH. Topical phenytoin nanostructured lipid carriers: design and development. Drug Dev Ind Pharm, 44, 144-157 (2018) https://doi.org/10.1080/03639045.2017.1386204.
Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R. Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries. Life Sci, 193, 64–76 (2018) https://doi.org/10.1016/J.LFS.2017.11.046.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Pramesh Panwar, Saurabh Kumar, Pallavi Chand, Ashish Singh Chauhan, Vikash Jakhmola
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
